Skip to main content
Caplight Logo









Shanghai Hepu Pharmaceutical Co., Ltd.

Shanghai Hepu Pharmaceutical Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://heppharma.com

Last Round

Early Funding

Jul 4, 2022

Est. Valuation

$12.3M

Total Funding Raised

$31.59M

Company Overview

Shanghai Hepu Pharmaceutical Co., Ltd. is a biotechnology company that researches and develops original new drugs for the treatment of hepatitis, diabetes, non-alcoholic fatty liver disease, and hyperlipidemia.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

synthetic peptideentry inhibitorhepatitis Bhepatitis Dbiotechdrug discoveryNTCP-targetedmetabolic diseaseclinical trialsNAFLDnon-alcoholic fatty liver diseaseHBVbiopharmapeptide therapeuticspreclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai Hepu Pharmaceutical Co., Ltd. Comparables

Compare Shanghai Hepu Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.

Shanghai Hepu Pharmaceutical Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Huahui Health Ltd.
83%
Suzhou HepaThera Biotech Co., Ltd.
80%
Drug Farm
77%

Shanghai Hepu Pharmaceutical Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJul 4, 2022
SeedNov 1, 2013

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 4, 2022

    $15M raised in early funding.

  • Nov 1, 2013

    $13M raised from Shanghai Hepu Pharmaceutical Co., Ltd.

Shanghai Hepu Pharmaceutical Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shanghai Hepu Pharmaceutical Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shanghai Hepu Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range3
Year Founded2010
Last FundingJul 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?